[EN] COMPOUNDS AND METHODS<br/>[FR] COMPOSÉS ET MÉTHODES
申请人:TEMPERO PHARMACEUTICALS INC
公开号:WO2013019621A1
公开(公告)日:2013-02-07
The present invention relates to novel retinoid-related orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.
Structure–Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against <i>Cryptosporidium</i> Reveals Remarkable Role of Fluorine
作者:Tanner J. Schubert、Edmund Oboh、Hannah Peek、Emily Philo、José E. Teixeira、Erin E. Stebbins、Peter Miller、Jonathan Oliva、Francis M. Sverdrup、David W. Griggs、Christopher D. Huston、Marvin J. Meyers